There are increasing challenges to the Quality management of pharmaceutical supply chains, for example:
Increasing complexity of the pharmaceutical supply chain
Increasing number of suppliers (many of ... Read more
Directive 2011/62/EU (‘’Falsified Medicines Directive’’) of 08 June2011 amending Directive 2001/83/EC describes requirements for excipients. e.g.
Article 46f requires the holder of the manufacturing authorisation to ensure ... Read more
The Directive on falsified medicines introduces mandatory, harmonised pan-European safety features for medicines at risk of falsification. With counterfeit medicines a clear and growing threat, ... Read more